The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.
Trump credited Regeneron Pharmaceuticals Inc's REGN.O therapeutic for his recovery. Trump received Regeneron's treatment last week after he was diagnosed with COVID-19.
by Frank Schnittger - Jan 14 41 comments
by Oui - Jan 10 58 comments
by Oui - Jan 21 6 comments
by IdiotSavant - Jan 15 20 comments
by Oui - Jan 20 31 comments
by Oui - Jan 20 4 comments
by Oui - Jan 16 8 comments
by Oui - Jan 13 89 comments
by Oui - Jan 216 comments
by Oui - Jan 2031 comments
by Oui - Jan 204 comments
by Oui - Jan 172 comments
by Oui - Jan 168 comments
by gmoke - Jan 16
by IdiotSavant - Jan 1520 comments
by Oui - Jan 1432 comments
by Frank Schnittger - Jan 1441 comments
by Oui - Jan 1389 comments
by Oui - Jan 1177 comments
by Oui - Jan 1058 comments
by Frank Schnittger - Jan 877 comments
by Oui - Jan 772 comments
by Frank Schnittger - Jan 710 comments
by Frank Schnittger - Jan 668 comments
by Frank Schnittger - Jan 611 comments
by Oui - Jan 659 comments
by Frank Schnittger - Jan 230 comments
by Frank Schnittger - Dec 3151 comments